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SIGNIFICANCE
Atopic dermatitis is a common skin disease characterized 
by dry and itchy skin with eczema flares. The disease is 
associated with changes in the skin microbiota, which con-
stitutes all microorganisms present on the skin surface. 
The greatest difference is due to increased abundance of 
Staphylococcus aureus, a bacterium that can cause skin 
infections and probably contributes to aggravation of the 
disease. This review aims to provide an overview of re-
cently published literature regarding changes in the skin 
microflora in atopic dermatitis and its association with di-
sease severity and exacerbation.
Atopic dermatitis is a common inflammatory skin di-
sease with a complex pathogenesis that includes im-
balanced immune system signalling, impaired skin 
barrier and enhanced Staphylococcus aureus skin colo-
nization. The skin bacterial communities are characte-
rized by increasing abundance of S. aureus, leading to 
reduced diversity compared with the bacterial commu-
nities on healthy skin, and increasing disease severity. 
In contrast, fungal communities are richer and more 
diverse on the skin of patients with atopic dermatitis, 
although distribution of the most common species is 
similar in patients and controls. Filaggrin deficiency 
in atopic dermatitis skin might be related to the en-
hanced skin colonization by S. aureus. In addition, S. 
aureus expressing variant virulence factors have been 
shown to elicit atopic dermatitis-like phenotypes in 
mice, indicating that specific S. aureus strains can in-
duce flare-ups. This review aims to provide an over-
view of the recent literature on the skin microbiome in 
atopic dermatitis.
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Atopic dermatitis (AD) is a common inflammatory skin disease that affects 10–20% of children and 
2–10% of adults in developed countries (1, 2). The 
pathogenesis of the disease is complex and includes im-
paired skin barrier function and an imbalanced immune 
system with enhanced Th2, Th17, and Th22 signalling 
(3). Furthermore, patients with AD have an increased 
burden of Staphylococcus aureus skin colonization, 
which is associated with disease severity and exacerba-
tion (4–8). Within recent years, where it has become pos-
sible to examine complete microbial communities using 
advanced DNA sequencing technologies, it is evident that 
cutaneous S. aureus is associated with decreased bacterial 
diversity on AD skin (8–13). The aim of this review is to 
provide an overview of the recent literature on the skin 
microbiome as well as microbe-host interactions in AD. 
There is no single established accepted definition of the 
term “microbiome” in the scientific community. Often, 
this term is defined as the composition of all microbial 
genes in a community (14), but it has been argued that 
this definition rather describes the “metagenome” and 
that the word “microbiome” should be defined as all 
microorganisms in a habitat (the “microbiota”), their 
genomes, and the surrounding environmental conditions 
(15). In this review, the latter definition is used.
Skin microorganisms can be identified using culture-
based assays, and complete microbial communities can 
be examined by DNA sequencing (Box 1) followed 
by diversity and taxonomy analysis (Box 2). Recently, 
Grogan et al. (16) have summarized the techniques used 
for studying the skin microbiome, and the methods are 
therefore not described in detail in this review.
HEALTHY SKIN MICROBIOME
The skin is an important first-line defence against patho-
genic microbial invasion. Tight connections between 
corneocytes in the stratum corneum form a physical 
barrier, and antimicrobial peptides and lipids secreted 
from keratinocytes and glands provide a chemical barrier 
(17). In addition, commensal skin microorganisms can 
impede growth of pathogens, either directly by secreting 
antimicrobial molecules, or indirectly by occupying 
space and competing for nutritional resources (18, 19). 
The skin microbiota consists of diverse organisms, 
including bacteria and fungi. In adults, the microbial 
community composition is rather stable over time, de-
spite of the constant exposure to external microorga-
nisms from other humans and the surrounding environ-
ment (20). How ever, the composition of the microbiota 
changes during puberty, with children having a more 
diverse microbiota compared with adults (21–23). 
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Bacteria constitute the greatest proportion of the micro-
biota, representing more than 70% of species in most 
skin areas (24). 16S rRNA gene sequence analysis has 
shown that Corynebacterium, Cutibacterium (formerly 
Propionibacterium (25)), Micrococcus, Staphylococcus, 
Streptococcus, Betaproteobacteria, and Gammaproteo-
bacteria are common skin-colonizing bacteria (9, 21, 
23, 24, 26). Microbial richness and Shannon-diversity 
are influenced by the microenvironmental conditions 
on the skin, including pH, moisture, sebum content, 
and topography (24, 26, 27). Sebaceous skin sites (e.g. 
facial areas and the upper part of the chest and back) are 
dominated by Cutibacterium acnes and are less diverse 
and rich compared with moist skin (e.g. nares, axillary 
vault, antecubital fossa, and popliteal fossa) and dry skin 
(e.g. volar forearm) (24, 26). C. acnes is also the most 
abundant species in dry skin, whereas no single bacte-
rial species is over-represented in moist skin, although 
Corynebacterium spp. and Staphylococcus spp. relative 
abundances are greatest (24). Fungi constitute 1–5% of 
the skin microbiota (24), with Malassezia being the most 
common and abundant habitant (27, 28).
SKIN MICROBIOME IN ATOPIC DERMATITIS
AD is clinically characterized by red, dry, and itchy skin, 
with eczema flares and disease exacerbation. Interestingly, 
the clinical presentation of AD changes with age (29). 
Infants (< 1 year) are primarily affected by acute lesions 
of the cheeks, scalp, neck, trunk, and extensor parts of 
the extremities. Children (2–12 years of age) are mostly 
affected by eczema at the antecubital and popliteal fossa, 
and adolescents and adults by chronic lesions comprising 
the head, neck, hands, and flexural areas (and sometimes 
widespread disease). Consequently, published studies 
on the skin microbiome in AD have focussed on distinct 
skin areas depending on the age group investigated. A 
major genetic risk factor of AD in Asian and Caucasian 
populations is loss-of-function mutations in the FLG 
gene encoding the skin protein filaggrin (30). Filaggrin is 
essential for the alignment of keratin in the corneocytes, 
and filaggrin breakdown products act as natural moisturi-
zing factors (NMFs) important for proper skin hydration. 
Thus, filaggrin is important for maintaining a functional 
skin-barrier. Th2 and Th22 cytokines can down-regulate 
FLG expression, and thus lead to filaggrin deficiency in 
AD independently of loss-of-function mutations in FLG 
(3). Filaggrin deficiency and reduced levels of NMFs and 
free fatty acids, followed by an increase in skin pH, lead 
to an altered skin ecology in AD (31–34). Also, micro-
bial communities are altered on AD skin compared with 
normal healthy skin, as described below.
Bacterial community on atopic dermatitis skin during 
infancy
As in healthy control skin, the skin microbial composition 
in AD differs between age groups, with distinct bacteria 
being over-represented at different ages (10, 21). Two 
case-control studies have compared the bacterial commu-
nity composition on skin from infants with and without 
AD (35, 36). Zheng et al. (35) examined the bacterial 
community composition in perioral skin in infants with 
clinical signs of AD at the sample site and in age-matched 
healthy controls. The microbial diversity was lower on 
AD skin compared with healthy control skin, with the 
largest difference observed between patients with severe 
AD and healthy controls. Streptococcus was the most 
common bacterial genus at the perioral skin, with mean 
relative abundances exceeding 40% in both healthy 
Box 1. Assays for examination of microbial organisms and 
communities
• Culture assays: Plating and culturing of samples in order to detect and isolate 
specific viable microorganisms of interest. Advantages of this method are 
the possibility to use isolated strains for additional analysis, e.g. testing 
for antimicrobial resistance and examine the gene content using molecular 
methods. Also, it is known that the detected microbes are alive and viable. 
Disadvantages are that it is difficult to detect microorganisms that do not 
grow easily under standard laboratory conditions and that it is not possible to 
examine the microbial community as a whole.
• Whole genome sequencing: Sequencing genomes of specific microorganism 
of interest allows to examine the genetic content and thus properties of the 
single strain. This method is especially useful for comparing strains and their 
relatedness, e.g. to examine the similarity of strains isolated from distinct skin 
sites within individuals. A disadvantage of this method is that only selected 
strains are examined.
• Targeted amplicon sequencing: Sequencing of selected variable regions of the 16S 
rRNA gene can be used to identify most bacteria in a sample, making it possible 
to examine the composition of the bacterial community. The transcriptional 
spacer regions ITS1/2 and variable regions of the 18S rRNA gene can be used 
to study eukaryotic microbial communities, such as fungal communities. An 
advantage of targeted amplicon sequencing is thus the ability to examine whole 
microbial communities, though this method has its limitations as it often is 
impossible to differentiate between related species. Another disadvantage of 
this method is that all available target DNA is sequenced, including DNA from 
microbial contaminants and human skin cells, which especially constitutes a 
problem for low biomass samples, such as skin samples.
• Metagenomic shot-gun sequencing: Shot-gun sequencing is used to examine 
the complete genomes of the microbiota. This allows to detect all species 
constituting the microbiota at the strain level as well as examining specific 
properties of the community, e.g. metabolic pathway genes. A disadvantage 
of shot-gun sequencing is that deep-sequencing is required in order to obtain 
a high resolution making the method very expensive. As a consequence, most 
metagenomic studies are based on minor sample sets. Another disadvantage, 
which also applies to the amplicon DNA sequencing method, is the lack of 
discrimination between live and dead organisms.
Box 2. Diversity and taxonomy analysis
• Alpha-diversity: Diversity within samples.
• Richness: the total number of species or unique sequences in a sample.
• Shannon Index: a diversity measure that takes into account both species 
richness and evenness.
• Beta-diversity: Diversity between samples.
• Pairwise comparison of community structures can be measured using 
distance-based methods, e.g.:
• Weighted UniFrac: Dissimilarity measure based on species presence/
absence data. Takes into account the phylogenetic relatedness of species.
• Unweighted UniFrac: Dissimilarity measure based on the relative 
abundances of species. Takes into account the phylogenetic relatedness 
of species.
• Jaccard: Dissimilarity measure based on species presence/absence data. 
Does not take into account the phylogenetic relatedness of species.
• Bray-Curtis: Dissimilarity measure based on the relative abundances 
of species. Does not take into account the phylogenetic relatedness 
of species.
• Ordination plots: Visualization of beta-diversity based on the pairwise 
distance measures. Samples with similar community structures are clustered 
together. The axes determine the degree of variance between samples.
• Hierarchical clustering: Samples are clustered in a dendrogram based on 
the pairwise distance measures.
• Taxonomy analysis: Analysis of species distributions in a community/sample.
A
ct
aD
V
A
ct
aD
V
A
d
v
a
n
c
e
s 
in
 d
e
rm
a
to
lo
g
y
 a
n
d
 v
e
n
e
re
o
lo
g
y
A
c
ta
 D
e
rm
a
to
-V
e
n
e
re
o
lo
g
ic
a
S. M. Edslev et al.360
Theme issue: Atopic dermatitis
control skin and lesional skin from patients with mild/
moderate AD. However, in the severe AD patient group, 
relative abundances of Streptococcus spp. were signifi-
cantly reduced and replaced with Staphylococcus spp, 
primarily S. aureus. In contrast, bacterial communities 
on skin from the cheeks, nose tip, antecubital fossa, and 
popliteal fossa were generally similar in infants with or 
without AD (36). Importantly, the AD group consisted 
of infants who not necessarily had developed AD or had 
active disease at the sampling time-points, which very 
well can influence the results. S. aureus was not identified 
in any of the skin samples (36), despite the fact that S. 
aureus is frequently detected on antecubital and popli-
teal fossa skin regions in older children and adults with 
AD (8, 10). Although this could indicate that S. aureus 
colonization at the antecubital and popliteal fossa is not 
an essential marker for AD during disease development 
in the first year of life, culture-based analysis has indi-
cated the opposite (37). Thus, Meylan et al. (37) found 
that frequencies of S. aureus colonization at axillary 
and antecubital fossa skin were significantly higher at 
the time of diagnosis among infants and toddlers (0–2 
years of age) developing AD compared with non-AD 
age-matched controls. However, frequencies of S. aureus 
colonization were less than 15% and thus remarkably 
lower compared with the prevalence in older children 
and adults with AD (6). In addition, S. aureus coloniza-
tion of the anterior nares, which is a major habitat for S. 
aureus in both healthy and AD individuals (6, 38), was 
not considered to be a risk factor for AD development 
among infants with familial predisposition (39). Thus, a 
possible role of cutaneous S. aureus colonization during 
development of AD still needs further investigation.
Bacterial community on atopic dermatitis skin during 
childhood and adulthood
Several studies have shown that bacterial communities 
on skin of children and adults with established AD are 
less diverse, and are dominated by increased proportions 
of S. aureus compared with communities on healthy skin 
(8–13, 21, 35). Quantification of cutaneous S. aureus 
abundances has shown that the proportional increase of S. 
aureus is due to a significant greater absolute abundance 
of S. aureus on AD lesional and non-lesional skin com-
pared with healthy control skin (40–42). No difference 
in absolute abundances of the 3 common skin bacteria 
Corynebacterium, Cutibacterium, and Streptococcus 
were observed between AD and healthy control skin in 
children (40). Thus, the increased relative abundance of 
S. aureus on AD skin is probably not due to decreased 
colonization with these bacteria, but mainly a result of 
an enhanced burden of S. aureus on the skin. This could 
also explain that the total bacterial load is significantly 
greater on AD skin compared with healthy control skin 
(Fig. 1) (40, 43).
Kong and colleagues (8) were the first to examine the 
temporal bacterial variation on antecubital and popli-
teal fossa skin in children during and after an AD flare 
episode (8, 12). Bacterial diversity was significantly 
reduced during flares at both skin sites, compared with 
baseline and post-flare samples. The decreased diversity 
during AD flares was associated with increased relative 
abundances of S. aureus, which exceeded 40% in many 
of the samples. The increase in relative abundances of 
S. aureus was accompanied by a decrease in the relative 
abundance of Streptococcus salivarius (8, 44), a com-
mensal bacteria of the oral cavity, intestines and skin that 
has been shown to possess anti-inflammatory potentials 
in vitro (45). In addition, higher proportions of S. sali-
varius contributed to greater bacterial diversity on the 
skin of the cheek, volar- and dorsal forearm in healthy 
infants with a family history of atopic diseases and thus 
at higher risk of developing AD (44). The proportional 
abundances of S. aureus decreased significantly at the 
post-flare sample time-point, but were still slightly higher 
compared with S. aureus proportional abundances in the 
healthy control samples (8, 12). Yet, no significant diffe-
rence in alpha-diversity was observed between baseline, 
post-flare, and healthy control skin, which could indicate 
that skin bacterial diversity is only reduced during flare-
ups. Several studies have compared alpha-diversity on 
lesional and non-lesional AD skin, but with different 
conclusions. Three studies found that the bacterial di-
versity was lower on lesional skin compared with non-
lesional skin (13, 21, 46), whereas 2 other studies found 
that the diversity was equally reduced on affected and 
un-affected AD skin compared with healthy control skin 
(9, 10). Neither age nor sampling sites can explain the 
Fig. 1. Absolute abundances of bacteria in atopic dermatitis (AD) 
skin and healthy skin. Bacterial densities are significantly greater on 
AD lesional skin compared with healthy control skin, which mainly is due 
to significantly increased abundances of S. aureus in AD lesional skin. S. 
aureus absolute abundances are also increased in AD non-lesional skin, 
but not as much as in lesional skin.
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conflicting results. These studies might indicate that it is 
not the eczema itself that drives the changes in diversity, 
but other AD-related factors in or on the skin that not 
only are associated with lesional skin areas (e.g. S. aureus 
colonization, lipid composition or pH). 
Clausen et al. (9) discovered that the bacterial com-
munity composition (beta-diversity) varied significantly 
between lesional and non-lesional skin areas in adult AD 
patients, with the greatest variance being due to a dif-
ferent distribution of Staphylococcal species. One-third 
of the lesional skin samples were dominated by S. aureus 
(relative abundances greater than 50%), whereas only a 
few non-lesional skin samples were characterized by high 
proportions of S. aureus. Instead, coagulase-negative 
staphylococcal species (CoNS), such as S. epidermidis 
and S. hominis, dominated the bacterial community on 
non-lesional skin in a majority of patients. In accordance, 
Baurecht et al. have shown that relative abundances of 
CoNS are reduced and S. aureus abundances increased 
in acute and chronic lesional skin compared with non-
lesional AD skin (46). Though the identified CoNS are 
common colonizers of moist skin, their abundances were 
lower on healthy control skin compared with non-lesional 
AD skin at the antecubital fossa (9, 46). It could thus 
be hypothesized that the skin ecology in AD supports 
enhanced staphylococcal growth on both lesional and 
non-lesional skin, and that changes in the distribution 
among the staphylococcal species towards greater abun-
dances of S. aureus can contribute to the development 
of eczema locally on the skin. However, no changes in 
the proportion of either S. epidermidis, S. hominis or S. 
capitis at the antecubital- and popliteal fossa during or 
after a flare-up episode was identified among paediatric 
AD patients (12), suggesting that a potential role for the 
CoNS spp. in AD still needs to be clarified. Furthermore, 
species level analysis might not be sufficient, as distinct 
strains within a species can have distinct phenotypes. For 
example, Nakatsuji et al. have shown that CoNS strains 
isolated from the skin of healthy individuals more often 
are capable of killing S. aureus compared with CoNS 
strains isolated from AD skin (42). Also, colonization 
of specific subspecies of S. aureus seems to be favoured 
in AD, as S. aureus clonal complex 1 (CC1) strains are 
more often detected on skin and in nares from AD pa-
tients compared with healthy controls (47). The increased 
prevalence of CC1 S. aureus colonization might be due to 
intrinsic factors in AD, e.g. CC1 S. aureus colonization 
have been associated with carriage of loss-of-function 
mutations in FLG (7), or due to extrinsic factors, such 
as treatment practice leading to selection of antibiotic 
resistance (48, 49).
Eukaryotic microbial community on atopic dermatitis 
skin
Few studies have examined the eukaryotic microbial 
community on AD skin, and only in adults and Asian 
populations (50–52). Focus has been on fungal commu-
nities, which was found to be richer and more diverse on 
AD lesional skin compared with healthy control skin (50, 
51). Malassezia, especially M. globosa and M. restricta, 
was the dominant fungus in both AD lesional skin and 
healthy control skin (50, 51). An increase in the propor-
tional abundance of M. dermatitis and M. sympodialis 
was identified on the skin of individuals with a history 
of AD (no active disease) compared with individuals 
without AD (52). However, no differences in the propor-
tions of these 2 species were found between lesional skin 
of AD patients with active disease and healthy control 
skin (51, 53). Another fungal species, Candida albicans, 
was found to be over-represented on AD lesional skin 
on the cheeks (presence in 100% of samples), compared 
with healthy control skin from the same area (presence 
in 10% of samples) (51). The literature regarding skin 
eukaryotic microbial communities in AD is limited, and 
thus, additional studies with more attendees are needed 
in order to validate the presented results.
Atopic dermatitis disease severity is associated with 
changes in skin microbial communities
Significant differences in alpha- and beta-diversity across 
AD severity scores have been identified in both lesional 
and non-lesional skin sites, with patients with more 
severe disease having the lowest bacterial diversity on 
the skin (9, 10, 13, 54). Brandwein et al. (10) found that 
the bacterial community composition in antecubital- and 
popliteal fossa in patients with mild/moderate AD was 
more similar to the community composition of healthy 
control skin than to skin areas in patients with severe 
AD, regardless of whether samples were collected from 
lesional or non-lesional skin. This finding supports the 
hypothesis that the AD phenotype, such as an overall 
impaired skin barrier and skin inflammation, has a wi-
despread effect on the skin microbial community and not 
only on lesional skin areas.
S. aureus skin and nasal colonization is significantly 
more prevalent among patients with more severe disease 
(6, 7, 55, 56), and increased relative abundances of S. au-
reus, at least at the antecubital fossa, have been associated 
with increasing AD severity scores (10–13). However, 
conflicting results regarding total S. aureus densities on 
skin in relation to AD severity have been published. Thus, 
S. aureus absolute abundances have been associated with 
increasing severity scores among adult patients (13, 57), 
whereas no association was detected in a paediatric AD 
population (54).
Studies investigating eukaryotic microbial commu-
nities on AD skin are sparse, but one study implies that 
there is an association between AD severity scores and 
the fungal community on skin, as beta-diversity analysis 
showed distinct community compositions in samples 
from patients with severe AD compared with samples 
from those with mild/moderate AD (51).
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MICROBE-HOST INTERACTIONS IN ATOPIC 
DERMATITIS
Microbiome studies have made it evident that microbial 
communities on AD skin differ from those of healthy 
skin, and that the greatest difference is due to an over-
representation and greater abundance of S. aureus on AD 
skin. What are the mechanisms behind these differences? 
Functional analysis studies suggest that the AD pheno-
type, including impaired skin barrier function, increased 
pH, and skin inflammation, can promote changes in the 
skin microbial communities (43, 58, 59). Moreover, S. 
aureus can induce skin inflammation and aggravate AD 
(12, 60–62). Thus, a vicious circle might exist, with filag-
grin deficiency in skin leading to enhanced colonization 
of S. aureus, which through the expression of virulence 
factors then can induce skin inflammation and contribute 
to further skin barrier impairment, and, in turn, can faci-
litate the maintenance of an imbalanced skin microbial 
community (Fig. 2). The mechanism behind these con-
nections is elaborated below.
Atopic dermatitis pathogenesis facilitates changes in skin 
microbial communities
In AD, loss-of-function mutations in the FLG gene have 
been associated with changes in the overall bacterial 
community composition on non-lesional AD skin (9, 46), 
as well as with an increased risk of S. aureus colonization 
on lesional skin and in anterior nares (7). These studies 
indicate that filaggrin can influence bacterial growth and 
colonization on the skin. In accordance, presence of the 
filaggrin breakdown products urocanic acid (UCA) and 
pyrrolidone carboxylic acid (PCA), which contribute to 
skin acidification, have been shown to reduce S. aureus 
growth in vitro (58). More neutral pH, reflecting the skin 
pH in AD, has been associated with increased expression 
of S. aureus genes involved in colonization, including 
the gene encoding clumping factor B, which mediates 
adherence to keratinocytes (58, 59). Thus, increased S. 
aureus colonization among AD patients with FLG loss-
of-function mutations (7) might be due to changes in 
skin pH caused by UCA and PCA deficiency. In addition 
to increased S. aureus adherence in epidermis, filaggrin 
deficiency is also associated with enhanced migration of 
S. aureus into the dermis skin layer. Nakatsuji et al. (43) 
showed that skin barrier impairment in mice, induced by 
genetic predisposition (FLG loss-of-function mutations) 
and physical skin disruptions (tape stripping), led to en-
hanced penetration of S. aureus into the dermis where it 
could activate the host immune system. In humans, the 
absolute abundance of S. aureus was significantly greater 
in dermis of AD lesional skin compared with healthy 
control skin, indicating that S. aureus can migrate more 
easily into the deeper skin layers of patients with AD 
with a disrupted skin barrier (43). Disrupted AD skin 
is also more permeable to allergens, which can trigger 
type I allergic responses in sensitized individuals. To 
corroborate this, patients with AD are also more often 
hypersensitive to a wide range of microbial allergens, in-
cluding allergens from S. aureus and the skin colonizing 
fungal species Malassezia furfur and Candida albicans, 
compared with the general population (63–65).
AD skin might not only be more susceptible to S. au-
reus colonization, but also more vulnerable to S. aureus 
virulence. Alpha-haemolysin (also known as alpha-
toxin), a virulence factor secreted by S. aureus, has thus 
been shown to adhere more easily to keratinocytes in AD 
skin compared with keratinocytes in healthy skin (66, 
67). Alpha-haemolysin adheres to sphingomyelin lipids 
in the membranes of keratinocytes, leading to cell lysis 
and contribution to skin barrier disruptions (68). The den-
sity of sphingomyelin lipids, and thus the amount of free 
adherence sites for alpha-haemolysin, is regulated by the 
enzyme acid sphingomyelinase. Filaggrin deficiency as 
well as Th2 cytokines promote down-regulation of acid 
sphingomyelinase, thus enhancing alpha-haemolysin 
binding efficiency (66, 67). Thus, filaggrin deficiency 
in AD probably both favours S. aureus colonization and 
enhanced S. aureus mediated cytotoxicity and immune 
activation (Table I).
S. aureus as an inducer of clinical atopic dermatitis
Byrd et al. (12) have shown that S. aureus isolated from 
AD skin, but not S. aureus from normal healthy skin, was 
able to induce skin inflammation in wild-type mice with 
no genetic predisposition. Skin inflammation, assessed 
by epidermal thickening and cutaneous infiltration of 
immune cells, including Th2 and Th17 cells, was more 
pronounced in mice inoculated with S. aureus from pa-
tients with more severe AD. This study highly suggests 
Fig. 2. Proposed connections between 
human factors involved in AD patho-
genesis and S. aureus colonization and 
virulence.
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that certain strains of S. aureus are able to elicit lesions 
similar to those observed in AD. The detected effect of 
S. aureus is probably mediated by the production of vi-
rulence factors, such as phenol-soluble modulins (PSM) 
and enterotoxins. 
Several studies indicate that S. aureus induced skin in-
flammation and barrier disruption in mice are dependent 
on secretion of PSM-alpha, which promotes interleukin 
(IL)-17A mediated pro-inflammatory responses in vitro 
(human keratinocytes) and in vivo (mice) (60, 69, 70). 
Another PSM, known as delta-toxin, was also able to 
mediate S. aureus induced skin inflammation in mice, an 
effect that probably is mediated by delta-toxin induced 
mast cell degranulation, IgE production and enhanced 
IL-4 expression (62, 71). Interestingly, PSM-alpha trans-
cripts are significantly more abundant in S. aureus iso-
lated from AD skin compared with those from S. aureus 
isolated from healthy control skin (60), and delta-toxin 
production has been found to be considerably higher 
among S. aureus from lesional skin compared with non-
lesional skin on patients with AD (62). These findings 
might explain why S. aureus strains isolated from AD 
lesional skin were better at eliciting skin inflammation 
compared with S. aureus from healthy skin (12).
S. aureus enterotoxins have also been proposed to be 
important mediators of S. aureus induced skin inflam-
mation. Thus, topical application of staphylococcal 
enterotoxin B (SEB) to skin have been shown to cause 
erythema and epidermal thickening in both healthy vo-
lunteers and patients with AD (72), an effect which 
likely is mediated by enhanced T-cell signalling (72, 
73). Studies indicates that S. aureus from AD skin more 
often carry genes encoding enterotoxins (sea, seb, sec, 
and sed) and more often produce these toxins compared 
with S. aureus isolated from non-AD individuals (73, 
74). Furthermore, carriage of enterotoxin producing S. 
aureus has been associated with increased AD severity 
(assessed by SCORAD) (73, 75).
In one study, alpha-haemolysin was also found to 
be produced more frequently by AD S. aureus (91% 
of isolates) compared with production rates among S. 
aureus from healthy volunteers (33% of isolates) (61), 
which in combination with AD genetic predisposition 
for enhanced binding efficiency of the toxin (66, 67) 
could make alpha-haemolysin a potent inducer of skin 
barrier disruptions in AD (61). However, two other 
studies found lower proportions of S. aureus producing 
alpha-haemolysin on AD skin (30–63% of isolates) (76, 
77) and a third study reported an alpha-haemolysin gene 
(hla) expression frequency of 59% among S. aureus na-
sal isolates from healthy carriers (78), highlighting that 
population-based differences and use of distinct assays 
can influence the results. Thus, future studies need to 
elucidate whether alpha-haemolysin, and other S. aureus 
toxins, is upregulated in S. aureus colonizing AD skin. 
The above-mentioned studies support the hypothesis 
that S. aureus virulence is a major driver of AD disease 
exacerbation and might even be a direct cause of flare-
ups. In order to cause disease, S. aureus must first co-
lonize the skin. S. aureus isolated from AD skin has an 
enhanced binding activity of clumping factor B, leading 
to increased adhering to corneocytes, compared with S. 
aureus from healthy skin (79). In addition, CC1 S. au-
reus, which is a dominant clone in AD (7, 79, 80), had a 
slightly higher binding affinity compared with other S. 
aureus lineages (79). Thus, the increased prevalence of 
S. aureus skin colonization in AD might both be due to 
host factors and S. aureus factors (58, 59, 79). A summary 
of the described S. aureus virulence factors shown to be 
involved in AD is given in Table II.
EFFECT OF ATOPIC DERMATITIS TREATMENTS 
ON SKIN MICROBIAL COMMUNITIES
Topical application of corticosteroid (glucocorticoids) 
based creams is a common treatment of AD lesions. 
Prospective studies examining the effect of topical 
corticosteroid treatment on skin microbial communities 
in AD, have shown that 4–6 weeks of treatment led 
to significant increases in bacterial Shannon-diversity 
and richness (40, 81), whereas 7–10 days of treatment 
had no influence on alpha-diversity, though an clinical 
improvement was observed (35). Thus, a possible effect 
of topical corticosteroid on skin microbial communities 
is dependent of several weeks of continuous treatment. 
Comparative studies also imply that topical corticosteroid 
Table I. The effect of filaggrin deficiency on S. aureus skin colonization and virulence
Effect of filaggrin deficiency 
Primary outcomes Secondary outcomes Refs
Increased skin pH Enhanced S. aureus growth and colonization (58, 59)
Impaired skin barrier Enhanced S. aureus migration through the epidermal barrier and into dermis (43)
Increased density of sphingomyelin lipids in keratinocyte membranes Enhanced binding of alpha-haemolysin (cytotoxic S. aureus virulence factor) (67)
Table II. Virulence factors upregulated in S. aureus isolated from 
atopic dermatitis skin compared with S. aureus from healthy 
control skin
Virulence factors Clinical outcomes Mediators Refs
PSM-alpha Skin inflammation 
Skin barrier disruptions
IL-17A signalling
Protease activity 
(60, 70)
Delta-toxin Skin inflammation IL-4 signalling
Mast cell degranulation
IgE release
(62, 71)
Alpha-haemolysin Skin barrier disruptions Keratinocyte lysis (61)
Enterotoxin B Skin inflammation T-cell signalling (72)
Clumping factor B S. aureus colonization Cell adherence (79)
PSM: phenol-soluble modulin; IL: interleukin.
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treatments have an effect on the skin microbial commu-
nity, as AD patients undergoing topical corticosteroid 
treatments prior to sample collections often have a more 
diverse bacterial population with lower relative abundan-
ces of S. aureus compared with non-treated patients (8, 
9, 81). This effect might be due to direct inhibition of 
S. aureus as well as to a general improvement on skin 
conditions due to the anti-inflammatory properties of 
corticosteroids (82).
A keystone treatment practice in AD is application of 
emollients and moisturizers, which restore skin barrier 
integrity and prevents flare-ups. Despite extensive use, 
little is known about what effect this treatment approach 
has on skin microbial communities, but one study in-
dicates that emollient application leads to decreased 
proportions of Staphylococcus spp. on AD lesional skin 
(83). Although it indeed would be interesting to examine 
the long-term effect of emollient usage on the skin micro-
biome, it might be challenging and ethically unjustifiable 
to set up such study, as it would include an AD patient 
group that will be denied treatment with emollients and 
moisturizers for a longer period.
One study has examined the effect of dupilumab treat-
ment, an anti-inflammatory systemic therapy offered to 
adults with severe and chronic AD, on the skin bacterial 
community (13). Sixteen weeks of treatment led to in-
creased alpha-diversity and a decrease in relative and 
absolute S. aureus abundances on lesional as well as 
non-lesional AD skin. However, this effect was lost 18 
weeks after treatment termination. Dupilumab inhibits 
IL-4/IL-13 signalling, and the study thus shows that 
reduction of Th2-mediated signalling may influence S. 
aureus skin colonization.
Another common treatment practice, at least in some 
countries, is topical application of fusidic acid, which 
is a narrow-spectrum antibiotic used against S. aureus. 
Unfortunately, bacterial growth of other common bacte-
rial species on skin, including CoNS, are also inhibited 
by fusidic acid (84), and recent studies have shown a 
high prevalence of fusidic acid resistant S. aureus on 
AD skin and nares (48, 49), signifying that alternative 
treatment regimens are needed for the control of S. aureus 
colonization. Future treatment approaches could include 
S. aureus anti-virulence therapy (71) or application of 
commensal skin bacteria with anti-S. aureus properties 
(42). Oral administered antibiotics might also impact the 
cutaneous bacterial community composition and select 
for antibiotic resistance among skin bacteria (85–87). 
CONCLUSION
Multiple studies have shown that increased abundance 
of S. aureus and loss of bacterial diversity on skin are 
associated with disease severity and flares in children 
and adults with AD. The enhanced burden of S. aureus 
skin colonization is probably facilitated by AD-related 
changes in the skin, including reduced levels of filaggrin 
and NMFs leading to increased skin pH and skin bar-
rier impairment. In addition, deficiency of commensal 
bacterial strains with S. aureus inhibitory properties may 
contribute to the increased density of S. aureus on AD 
skin. Functional assays indicate that cutaneous S. aureus 
can exacerbate AD by expressing virulence factors that 
can induce skin inflammation and skin barrier disruption. 
Thus, changes in the composition of the skin bacterial 
community may be an important inducer of the clinical 
manifestations in AD patients with established disease. 
Whether bacterial community dysbiosis is also conside-
red to be present prior to AD development is still unclear, 
and needs further investigation. Increasing knowledge 
regarding S. aureus as a potent promoter of AD exacerba-
tion, has highlighted the skin microbial community as a 
potential target for future treatment strategies, and is a 
research field of great interest. Future studies are needed 
to explore the potentials, efficiency and safety of these 
novel anti-bacterial treatment approaches.
The authors have no conflicts of interest to declare. 
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